Literature DB >> 22653489

Infliximab treatment of pancreatitis complicating acute kawasaki disease.

Susan G Jimenez-Fernandez1, Adriana H Tremoulet.   

Abstract

Kawasaki disease can be associated with gastrointestinal complications, including pancreatitis. We describe a child in whom infliximab infusion for intravenous immunoglobulin-resistant Kawasaki disease coincided with marked clinical improvement of the patient's acute pancreatitis.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22653489      PMCID： PMC3444621          DOI： 10.1097/INF.0b013e31826108c2

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  13 in total

1.  Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment.

Authors:  J K Triantafillidis; P Cheracakis; I A Hereti; N Argyros; E Karra
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

2.  Re: Triantafillidis et al.--Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment.

Authors:  D S Fefferman; M Alsahli; P J Lodhavia; S A Shah; R J Farrell
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

3.  Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis.

Authors:  J G Norman; G W Fink; J Messina; G Carter; M G Franz
Journal:  Surgery       Date:  1996-09       Impact factor: 3.982

4.  CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease.

Authors:  T J Brown; S E Crawford; M L Cornwall; F Garcia; S T Shulman; A H Rowley
Journal:  J Infect Dis       Date:  2001-08-22       Impact factor: 5.226

5.  General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations.

Authors:  S Amano; F Hazama; H Kubagawa; K Tasaka; H Haebara; Y Hamashima
Journal:  Acta Pathol Jpn       Date:  1980-09

6.  Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis.

Authors:  C B Hughes; L W Gaber; A B Mohey el-Din; H P Grewal; M Kotb; L Mann; A O Gaber
Journal:  Am Surg       Date:  1996-01       Impact factor: 0.688

7.  Associated symptoms in the ten days before diagnosis of Kawasaki disease.

Authors:  Annette L Baker; Minmin Lu; L LuAnn Minich; Andrew M Atz; Gloria L Klein; Rosalind Korsin; Linda Lambert; Jennifer S Li; Wilbert Mason; Elizabeth Radojewski; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2008-11-28       Impact factor: 4.406

8.  Infliximab: a new therapeutic agent in acute pancreatitis?

Authors:  Nevin Oruc; A Omer Ozutemiz; Vahit Yukselen; Deniz Nart; Handan Ak Celik; Gul Yuce; Yucel Batur
Journal:  Pancreas       Date:  2004-01       Impact factor: 3.327

9.  Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression.

Authors:  J G Norman; G W Fink; M G Franz
Journal:  Arch Surg       Date:  1995-09

10.  Pancreatitis in Kawasaki disease.

Authors:  J Stoler; J A Biller; R J Grand
Journal:  Am J Dis Child       Date:  1987-03
View more
  6 in total

Review 1.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 2.  Role of pancreatic fat in the outcomes of pancreatitis.

Authors:  Chathur Acharya; Sarah Navina; Vijay P Singh
Journal:  Pancreatology       Date:  2014-07-01       Impact factor: 3.996

3.  Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections.

Authors:  Pawan Noel; Krutika Patel; Chandra Durgampudi; Ram N Trivedi; Cristiane de Oliveira; Michael D Crowell; Rahul Pannala; Kenneth Lee; Randall Brand; Jennifer Chennat; Adam Slivka; Georgios I Papachristou; Asif Khalid; David C Whitcomb; James P DeLany; Rachel A Cline; Chathur Acharya; Deepthi Jaligama; Faris M Murad; Dhiraj Yadav; Sarah Navina; Vijay P Singh
Journal:  Gut       Date:  2014-12-10       Impact factor: 23.059

4.  Intravenous Immunoglobulin Infusion Reactions in Kawasaki Disease Patients Who Undergo Sedation.

Authors:  Elizabeth Nguyen; Daniel Hershey; Gale Romanowski; Adriana Tremoulet
Journal:  J Pediatr Pharmacol Ther       Date:  2020

5.  Typical Kawasaki Disease Presenting With Pancreatitis and Bilateral Parotid Gland Involvement: A Case Report and Literature Review.

Authors:  Matteo Botti; Giorgio Costagliola; Rita Consolini
Journal:  Front Pediatr       Date:  2018-04-11       Impact factor: 3.418

6.  Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.

Authors:  Chun-Ling Han; Suo-Lin Zhao
Journal:  Med Sci Monit       Date:  2018-10-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.